Afghanistan vs Sao Tome and Principe: HIV-positive TB patients on ART (antiretroviral therapy)
Afghanistan
100.0%
in 2024
Sao Tome and Principe
100.0%
in 2024
Afghanistan rank
1st
Sao Tome and Principe rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Afghanistan
- Sao Tome and Principe
How they compare
Afghanistan currently reports 100.0% against 100.0% in Sao Tome and Principe, a difference of 0.0%.
The two have swapped places 1 time across 14 shared years of data; in 2009 it was Afghanistan ahead.
Afghanistan ranks 1st and Sao Tome and Principe ranks 1st of 144 countries.
Across the 3 decades both report, Afghanistan averaged higher in 1 and Sao Tome and Principe in 1.
Head to head by decade
| Decade | Afghanistan | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 30.0% | 70.0% | Afghanistan |
| 2010s | 78.8% | 94.2% | 15.5% | Sao Tome and Principe |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Afghanistan or Sao Tome and Principe?
- Afghanistan, at 100.0% against 100.0% in Sao Tome and Principe as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Afghanistan and Sao Tome and Principe?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Sao Tome and Principe?
- 14 years are reported by both, from 2009 to 2024.
- How do Afghanistan and Sao Tome and Principe rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Afghanistan ranks 1st and Sao Tome and Principe ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.